Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients


"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

African Pharmaceutical Market - Industry Analysis & Forecast 2017-2030

Published On : 2018-01-30 Report Page : 240 Category: Healthcare

Africa Pharmaceuticals Market Outlook, 2017-2030

Market Segmentation

Africa is the only pharmaceutical market where genuinely high growth is still achievable, value of Africa’s pharmaceutical industry jumped to USD 28.56 billion in 2017 from just USD 5.5 billion a decade earlier. That growth is continuing at a rapid pace: we predict the market will be worth USD 56 billion to USD 70 billion by 2030. It is opportunistic for multinationals and pharmaceutical companies seeking new sources of growth as developed markets stagnate while patients will also gain access to medicines previously unavailable on the continent.

Primary Survey Breakdown

Market Dynamics

Africa’s pharmaceutical markets are growing in every segment, given that between 2017 and 2030, prescription drugs are forecast to grow at a compound annual growth rate of 6.5%, generics at 10%, over-the-counter medicines at 7.1%, and medical devices at 12.1%. Increasing urbanisation, healthcare capacity and supportive business environment are the drivers of the Africa pharmaceutical market. For early movers in order to pursue competitive advantage requires focus on pockets of growth like much of the opportunity lies not at country level, but in cities. According to the analysis, 37% of African consumers are concerted in 30 cities, which will have more consuming households than Australia and the Netherlands combined by 2025. Addressing supply and distribution challenges, building stronger team and forging partnerships are the “to win strategies” as global pharmaceutical companies need local business partners like manufacturers, packaging companies, and distributor in order to help them navigate the continent’s many markets, with their widely varying consumer preferences, price points, manufacturing, and distribution infrastructures.

On the Basis of Therapeutic Class, Africa Pharmaceuticals Market

    • Oncology
    • Central Nervous System
    • Reproductive Medicine & Women’s Health
    • Cardiovascular
    • Metabolic
    • Orhthopaedics
    • Endocrine
    • Antiviral
    • Diabetes
    • Antibiotic
    • Gastrointestinal
    • Genitourinary
    • Respiratory
    • Ophthalmic
    • Antifungal
    • Musculoskeletal
    • Hematology
    • Radiology
    • Dermatology
    • Phototherapy
    • Antihelminthic

On the Basis of Drug Categories, Africa Pharmaceuticals Market

    • Stimulants
      • Cocaine
      • Methamphetamines
      • Amphetamines
      • Ritalin
      • Cylert
    • Inhalants
      • Glues
      • Paint thinner
      • Gasoline
      • Laughing gas
      • Aerosol sprays
    • Cannabinoids
      • Hashish
      • Marijuana
    • Depressants
      • Barbiturates
      • Benzodiazepines
      • Flunitrazepam
      • GHB (Gamma-hydroxybutyrate)
      • Methaqualone
      • Alcohol
      • Tranquillisers
    • Opioids & Morphine Derivatives
      • Codeine
      • Fentanyl and fentanyl analogs
      • Heroin
      • Morphine
      • Opium
      • Oxycodone HCL
      • Hydrocodone bitartrate, acetaminophen
    • Anabolic Steroids
      • Anadrol
      • Oxandrin
      • Durabolin
      • Stanozol
      • Dianabol
    • Hallucinogens
      • LSD (lysergic acid diethylamide)
      • Mescaline
      • Psilocybin
      • Magic Mushrooms
    • Prescription Drugs
      • Opiods: Codeine, Oxycodone, Morphine
      • Central nervous system depressants: barbiturates, benzodiazepines
      • Stimulants: dextroamphetamine, methylphenidate

On the Basis of Distribution Channel, Africa Pharmaceuticals Market

    • Pharmacy/OTC Stores
    • Retail Stores
    • Online Channel

On the Basis of Countries, Africa Pharmaceuticals Market

    • South Africa Pharmaceutical Market
    • Nigeria Pharmaceutical Market
    • Morocco Pharmaceutical Market
    • Kenya Pharmaceutical Market
    • Ghana Pharmaceutical Market
    • Algeria Pharmaceutical Market
    • Tunisia Pharmaceutical Market
    • Tanzania Pharmaceutical Market
    • Sudan Pharmaceutical Market
    • Rest of Africa Pharmaceutical Market

Key Players Included In Africa Pharmaceuticals Market Report

Market Players

Market Share (%)

Adcock Ingram




Merck & Co.


Johnson & Johnson















Report Scope

The market research report titled “Africa Pharmaceuticals Market” by Goldstein Research is the comprehensive review of market drivers, trends, opportunities, issues and restraints in addition to This report analyses the Africa markets for pharmaceuticals in USD Million. The report provides separate comprehensive analytics for the South Africa, Tanzania, Algeria, Sudan, Kenya, Morocco, Ghana and Tunisia pharmaceuticals market. The country analysis provides insights about the target and potential markets for pharmaceuticals across the Africa continent.

The market study includes annual estimates and forecast data on the basis of historical market analysis (2016-2017), current market analysis (2018) & forecast analysis (2019-2030) are derived from primary and secondary research. The research reports covers the Trade Data (Export & Import), By value & volume, Sales (in USD), Investment Flow Analysis, Pipeline Products Insights, Competitive Analysis of Players which includes mergers & acquisition activities, financial analysis, Start-ups associated, global presence, patents, product portfolio, brand recognition & market competition.

Market Study Pattern:

Product Analysis

  • Usage pattern (in-depth trend analysis) of pharmaceuticals market (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • Applications of the pharmaceuticals market products (segment and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

Epidemiology Data

  • Country-specific presence of target audience that include research organizations, pharmacies, drug manufacturers and the other major end users.

Manufacturer Analysis

  • Fast turn-around analysis of user response to market events and trends
  • Pattern analysis of usage of pharmaceuticals products by users involved

Brand/Product Perception Matrix

  • Comprehensive study of end user perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

Alternative Products: Impact analysis

It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (Patient pool, epidemiology of disease, preference towards OTC’s) and Macroeconomic indicators (investment rate and FDA regulations).


African Pharmaceutical Market - Industry Analysis & Forecast 2017-2030

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747